Spectrum and Assessment of TAVR Accessory Devices (Valvuloplasty Balloons, Neuroprotection Systems, and More)

Valve Degeneration and Mobility Considerations: Assessing Clinical Relevance

FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways

Cerebral Embolic Protection II: The Keystone Deflector - Design Features and Updates From Deflect III and Reflect Clinical Trials

Transfemoral Large Hole Closure Devices: Manta, Inseal, and Others

New Valvuloplasty Devices II: InterValve V8 Balloon Valvuloplasty - Technical Advantages and Clinical Applications

New Valvuloplasty Devices III: Bard TRUE and TRUE-Flow Balloon Valvuloplasty - Technical Advantages and Clinical Applications

New Valvuloplasty Devices I: Pi-cardia Leaflex Aortic Valve Remodeling Therapy

Surveying the Global Landscape of TAVR Newcomers

Xeltis: Design and Clinical Updates